Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
Neuroscience ; 143(2): 395-405, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-16973297

ABSTRACT

Schizophrenia is thought to be associated with abnormalities during neurodevelopment although those disturbances usually remain silent until puberty; suggesting that postnatal brain maturation precipitates the emergence of psychosis. In an attempt to model neurodevelopmental defects in the rat, brain cellular proliferation was briefly interrupted with methylazoxymethanol (MAM) during late gestation at embryonic day 17 (E17). The litters were explored at pre- and post-puberty and compared with E17 saline-injected rats. We measured spontaneous and provoked locomotion, working memory test, social interaction, and prepulse inhibition (PPI). As compared with the saline-exposed rats, the E17 MAM-exposed rats exhibited spontaneous hyperactivity that emerged only after puberty. At adulthood, they also exhibited hypersensitivity to the locomotor activating effects of a mild stress and a glutamatergic N-methyl-D-aspartate receptor antagonist (MK-801), as well as PPI deficits whereas before puberty no perturbations were observed. In addition, spatial working memory did not undergo the normal peri-pubertal maturation seen in the sham rats. Social interaction deficits were observed in MAM rats, at both pre- and post-puberty. Our study further confirms that transient prenatal disruption of neurogenesis by MAM at E17 is a valid behavioral model for schizophrenia as it is able to reproduce some fundamental features of schizophrenia with respect to both phenomenology and temporal pattern of the onset of symptoms and deficits.


Subject(s)
Behavior, Animal/physiology , Brain/growth & development , Prenatal Exposure Delayed Effects , Psychotic Disorders/physiopathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Behavior, Animal/drug effects , Brain/drug effects , Disease Models, Animal , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Excitatory Amino Acid Antagonists/pharmacology , Female , Inhibition, Psychological , Interpersonal Relations , Maze Learning/drug effects , Maze Learning/physiology , Methylazoxymethanol Acetate/analogs & derivatives , Motor Activity/drug effects , Motor Activity/physiology , Pregnancy , Psychotic Disorders/etiology , Rats , Recognition, Psychology/drug effects , Recognition, Psychology/physiology , Reflex, Startle/drug effects , Reflex, Startle/physiology , Time Factors
3.
Behav Pharmacol ; 15(4): 287-92, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15252279

ABSTRACT

We investigated the cognitive consequences of a prenatal injection of the mitotic inhibitor methylazoxymethanol (MAM) into pregnant rats at embryonic day 15 (E15) or 17 (E17). The male offspring were tested when adult on a version of the radial-arm maze task that assesses spatial working memory with an extended delay, where performance is dependent, in part, on the hippocampal-prefrontal circuit. A major impairment of spatial learning was observed in E15 MAM rats. However, the E17 MAM rats did learn the rule but were impaired selectively in the 30-min delay-interposed task. Morphologically, the E15 MAM rats exhibited dramatic gross brain abnormalities, whereas the E17 MAM animals displayed aberrant cell migration in the hippocampus and a disrupted laminar pattern in the neocortex. These results suggest that late gestational MAM injection (E17) causes a cognitive impairment in a prefrontal cortex-hippocampus-dependent working memory task. This approach could provide a new developmental model of disorders associated with working memory deficits, such as schizophrenia.


Subject(s)
Hippocampus/abnormalities , Memory Disorders/physiopathology , Methylazoxymethanol Acetate/analogs & derivatives , Methylazoxymethanol Acetate/toxicity , Prefrontal Cortex/abnormalities , Prenatal Exposure Delayed Effects , Abnormalities, Drug-Induced/etiology , Abnormalities, Drug-Induced/physiopathology , Animals , Disease Models, Animal , Drug Administration Schedule , Female , Hippocampus/drug effects , Male , Maze Learning/drug effects , Memory Disorders/chemically induced , Methylazoxymethanol Acetate/administration & dosage , Organ Size/drug effects , Prefrontal Cortex/physiopathology , Pregnancy , Rats , Rats, Sprague-Dawley , Time Factors
4.
Behav Pharmacol ; 11(3-4): 257-68, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11103880

ABSTRACT

Neonatal ventral hippocampal lesions in the rat result in post-pubertal onset of behavioural abnormalities, modelling some aspects of schizophrenia. We further assessed the behavioural effects of neonatal lesions in rats in a variety of cognitive tasks and in the prepulse inhibition (PPI) of startle response paradigm. Prepubescent, lesioned rats exhibited startle responses and PPI similar to controls whereas, at adulthood, they showed a deficit in PPI. Lesioned rats acquired both passive and active avoidance responses. However, compared to controls, they showed a deficit in passive avoidance retention and in acquisition of active avoidance responses. In a cued Morris water-maze task, lesioned rats demonstrated adequate sensorimotor functions and appropriate motivation to escape from water. However, they were impaired in place learning and in remembering the location of a submerged platform. In conclusion, neonatal ventral hippocampal lesions result in the post-pubertal emergence of long-lasting deficits in sensorimotor gating and in the capacity to acquire and retain information in tests of spatial and avoidance learning. Therefore, this neurodevelopmental model of schizophrenia seems to exhibit an interesting degree of validity in possibly simulating some cognitive impairments and sensorimotor gating deficits frequently observed in psychotic patients.


Subject(s)
Hippocampus/pathology , Learning Disabilities/psychology , Maze Learning , Schizophrenia/physiopathology , Animals , Avoidance Learning , Cognition Disorders/etiology , Disease Models, Animal , Hippocampus/growth & development , Rats , Rats, Sprague-Dawley , Reflex, Startle/physiology
5.
Neuroreport ; 9(12): 2887-91, 1998 Aug 24.
Article in English | MEDLINE | ID: mdl-9760140

ABSTRACT

The conditioned place preference (CPP) induced by cocaine 2.5 mg/kg was measured in rats pre-exposed to ethanol (14 days with only 10% v/v ethanol followed by a free choice between ethanol solution and water for 14 days). Rats were divided according to their alcohol intake during the free choice period into low-drinking (<3 g/kg per day), intermediate-drinking and high-drinking (> 4 g/kg per day) rats. Cocaine-induced CPP was not modified in high-drinking rats relative to controls. Low-drinking rats had a lower CPP than high-drinking rats and controls. We conclude that pre-exposure to alcohol did not sensitize to the cocaine rewarding effects, and that alcohol low-drinking rats showed the lowest preference for cocaine.


Subject(s)
Central Nervous System Depressants/pharmacology , Cocaine/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Ethanol/pharmacology , Alcohol Drinking/psychology , Animals , Conditioning, Operant/drug effects , Male , Rats , Reward
6.
J Pharmacol Exp Ther ; 286(2): 688-96, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9694922

ABSTRACT

The conditioned place preference (CPP) induced by increasing doses (1.25-40 mg/kg) of cocaine or the specific dopamine uptake inhibitor GBR12783 was investigated in rats previously treated with cocaine (10 or 20 mg/kg), GBR12783 (10 mg/kg) or morphine (10 mg/kg) for 15 days. In solvent-pretreated rats, cocaine- and GBR12783-induced CPPs were biphasic, with the highest scores observed at 20 mg/kg. Prior exposure to GBR12783 sensitized the rats to the rewarding effects of low doses of either GBR12783 or cocaine. Pretreatment with cocaine 20 mg/kg, but not 10 mg/kg, sensitized the rats to its own rewarding effects. Furthermore, it was less efficient than GBR12783 in sensitizing the animals to the rewarding effects of both drugs. These data confirm the major role of dopamine uptake inhibition in the sensitization process. On the other hand, the magnitude of CPP induced by a high dose of both drugs (20 mg/kg) was decreased after pretreatment with either GBR12783 or cocaine, reaching the lower scores observed at 40 mg/kg. This decrease was unrelated to altered anxiety level but was associated with sensitization to stereotypies. Morphine pretreatment modified neither the CPP induced by high doses of cocaine or GBR12783 nor cocaine- or GBR12783-induced stereotypies. However, prior exposure to morphine sensitized the rats to the rewarding effects of cocaine (2.5 mg/kg) but not to those of GBR12783, suggesting that other mechanisms working in concert with dopamine may facilitate the rewarding effect of cocaine without affecting that of GBR12783.


Subject(s)
Dopamine Uptake Inhibitors/pharmacology , Piperazines/pharmacology , Reward , Animals , Anxiety/psychology , Cocaine/pharmacology , Conditioning, Operant/drug effects , Image Processing, Computer-Assisted , Male , Morphine/pharmacology , Narcotics/pharmacology , Rats , Rats, Sprague-Dawley , Stereotyped Behavior/drug effects
7.
Neuroreport ; 7(18): 2839-42, 1996 Nov 25.
Article in English | MEDLINE | ID: mdl-9116192

ABSTRACT

The rewarding and locomotor effects of the specific dopamine uptake inhibitor GBR12783 (2.5-20 mg kg-1, i.p.) were compared with those of cocaine. For both drugs, all doses produced a conditioned place preference (CPP), even the dose of 2.5 mg kg-1, which did not modify the locomotor activity. Despite an equivalent locomotor stimulation, the magnitude of CPP induced by cocaine (10 mg kg-1) was greater than that induced by the same dose of GBR12783. This confirms the involvement of dopamine uptake inhibition in reward, but underlines differences in relative efficacies in rewarding and motor effects of both drugs and suggests that these two properties are, at least in part, separable anatomically or functionally.


Subject(s)
Cocaine/pharmacology , Conditioning, Operant/drug effects , Dopamine Uptake Inhibitors/pharmacology , Piperazines/pharmacology , Animals , Cocaine/administration & dosage , Dopamine Uptake Inhibitors/administration & dosage , Injections, Intraperitoneal , Male , Motor Activity/drug effects , Piperazines/administration & dosage , Rats , Rats, Sprague-Dawley , Reward
SELECTION OF CITATIONS
SEARCH DETAIL